Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. A Phase 2 Study.
Phase 2
18 Years
75 Years
18 Years
75 Years
Not Enrolling
Both
Colorectal Cancer
Both
Colorectal Cancer
Trial Information
Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. A Phase 2 Study.
Inclusion Criteria:
Colorectal cancer Hepatic metastases unresectable by classical surgery Performance status
< 2
Exclusion Criteria:
-
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Liver recurrence rate at 3 months after treatment
Principal Investigator
Serge EVRARD, Pr
Investigator Role:
Principal Investigator
Investigator Affiliation:
Institut Bergonié
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
IB2003-11
NCT ID:
NCT00210106
Start Date:
June 2003
Completion Date:
December 2008
Related Keywords:
- Colorectal Cancer
- Radiofrequency ablation
- Colorectal cancer
- Liver metastases
- Colorectal Neoplasms
- Neoplasm Metastasis
Name | Location |
|---|
